Skip to main content

Advertisement

Log in

Comparison of quality of life between melanoma and non-melanoma skin cancer patients

  • Clinical Report
  • Published:
European Journal of Dermatology

Abstract

Background

The impact of skin cancers on patients’ health-related quality of life (HRQoL) is often overlooked, and direct comparisons between melanoma and non-melanoma skin cancer (NMSC) are rare.

Objectives

The aim of this study was to compare HRQoL in patients with melanoma and NMSC.

Materials and Methods

Participants were unselected, consecutive adult patients with a diagnosis of melanoma at the time of wide excision, or NMSC at the time of surgery. HRQoL was measured using the two scales of Skindex-17. The 12-item General Health Questionnaire (GHQ-12) was used to identify patients with possible anxiety or depression.

Results

The study population included 433 patients: 65 with melanoma and 368 with NMSC. Skindex-17 symptom mean scores were higher in NMSC than in melanoma patients. Melanoma patients had significantly higher scores for the item “feeling depressed”. The percentage of GHQ-12 cases (with possible non-psychotic, minor psychiatric disorders) was significantly higher in patients with melanoma (32.8%) compared to NMSC patients (8.7%).

Conclusion

NMSC places a greater burden of symptoms on patients than melanoma, while the psychological impact of melanoma is higher.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol 2014; 810: 120–40.

    PubMed  Google Scholar 

  2. Chen SC. Health-related quality of life in dermatology: introduction and overview. Dermatol Clin 2012; 30: 205–8.

    Article  CAS  PubMed  Google Scholar 

  3. Blackford S, Roberts D, Salek MS, Finlay A. Basal cell carcinomas cause little handicap. Qual Life Res 1996; 5: 191–4.

    Article  CAS  PubMed  Google Scholar 

  4. Schlesinger-Raab A, Schubert-Fritschle G, Hein R, et al. Quality of life in localised malignant melanoma. Ann Oncol 2010; 21: 2428–35.

    Article  CAS  PubMed  Google Scholar 

  5. Rhee JS, Matthews BA, Neuburg M, Smith TL, Burzynski M, Nattinger AB. Skin cancer and quality of life: assessment with the Dermatology Life Quality Index. Dermatol Surg 2004; 30: 525–9.

    PubMed  Google Scholar 

  6. Sampogna F, Tabolli S, Abeni D. Impact of different skin conditions on quality of life. G Ital Dermatol Venereol 2013; 148: 255–61.

    CAS  PubMed  Google Scholar 

  7. Beesley VL, Smithers BM, Khosrotehrani K, et al. Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia. Psychooncology 2015; 24: 763–70.

    Article  PubMed  Google Scholar 

  8. Kasparian NA, McLoone JK, Butow PN. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 2009; 145: 1415–27.

    Article  PubMed  Google Scholar 

  9. Kasparian NA. Psychological stress and melanoma: are we meeting our patients’ psychological needs? Clin Dermatol 2013; 31: 41–6.

    Article  PubMed  Google Scholar 

  10. Cornish D, Holterhues C, van de Poll-Franse LV, Coebergh JW, Nijsten T. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol 2009; 20: vi51-8.

  11. Schubert-Fritschle G, Schlesinger-Raab A, Hein R, et al. Quality of life and comorbidity in localized malignant melanoma: results of a German population-based cohort study. Int J Dermatol 2013; 52: 693–704.

    Article  PubMed  Google Scholar 

  12. Gaulin C, Sebaratnam DF, Fernandez-Penas P. Quality of life in non-melanoma skin cancer. Australas J Dermatol 2015; 56: 70–6.

    Article  PubMed  Google Scholar 

  13. Steinbauer J, Koller M, Kohl E, Karrer S, Landthaler M, Szeimies RM. Quality of life in health care of non-melanoma skin cancer - results of a pilot study. J Dtsch Dermatol Ges 2011; 9: 129–35.

    PubMed  Google Scholar 

  14. Chren MM, Sahay AP, Bertenthal DS, Sen S, Landefeld CS. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol 2007; 127:1351–7.

    Article  CAS  PubMed  Google Scholar 

  15. Ventura M, Fusco D, Bontempi K, Colais P, Davoli M. Regional Outcome Evaluation Program (P.Re.Val.E.): reduction of inequality in access to effective health care in the Lazio region of Italy (2012-2015). PLoS One 2018;13:e0194972.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual, 8th Ed. New York: Springer, 2017.

    Book  Google Scholar 

  17. Bichakjian CK, Olencki T, Aasi SZ, et al. Basal Cell Skin Cancer, Version 1. 2016. NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016;14:574–97.

    Article  PubMed  Google Scholar 

  18. Tabolli S, Sampogna F, Pagliarello C, Paradisi A, Spagnoli A, Abeni D. Disease severity evaluation among dermatological outpatients: a comparison between the assessments of patients and physicians. J Eur Acad Dermatol Venereol 2012; 26: 213–8.

    Article  CAS  PubMed  Google Scholar 

  19. Sampogna F, Spagnoli A, Di Pietro C, et al. Field performance of the Skindex-17 quality of life questionnaire: a comparison with the Skindex-29 in a large sample of dermatological outpatients. J Invest Dermatol 2013;133:104–9.

    Article  CAS  PubMed  Google Scholar 

  20. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133:1433–40.

    Article  CAS  PubMed  Google Scholar 

  21. Nijsten TE, Sampogna F, Chren MM, Abeni DD. Testing and reducing skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol 2006;126: 1244–50.

    Article  CAS  PubMed  Google Scholar 

  22. Goldberg D. The Detection of Psychiatric Illness by Questionnaire. London: Oxford University Press, 1972.

    Google Scholar 

  23. Picardi A, Abeni D, Mazzotti E, et al. Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12-item General Health Questionnaire (GHQ-12). J Psychosom Res 2004; 57: 219–23.

    Article  PubMed  Google Scholar 

  24. Al-Shakhli H, Harcourt D, Kenealy J. Psychological distress surrounding diagnosis of malignant and nonmalignant skin lesions at a pigmented lesion clinic. J Plast Reconstr Aesthet Surg 2006; 59: 479–86.

    Article  CAS  PubMed  Google Scholar 

  25. Boyle DA. Psychological adjustment to the melanoma experience. Semin Oncol Nurs 2003;19:70–7.

    Article  PubMed  Google Scholar 

  26. Trask PC, Paterson AG, Hayasaka S, Dunn RL, Riba M, Johnson T. Psychosocial characteristics of individuals with non-stage IV melanoma. J Clin Oncol 2001; 19: 2844–50.

    Article  CAS  PubMed  Google Scholar 

  27. Burdon-Jones D, Thomas P, Baker R. Quality of life issues in non-metastatic skin cancer. Br J Dermatol 2010; 162: 147–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesca Sampogna.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sampogna, F., Paradisi, A., Iemboli, M.L. et al. Comparison of quality of life between melanoma and non-melanoma skin cancer patients. Eur J Dermatol 29, 185–191 (2019). https://doi.org/10.1684/ejd.2019.3523

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2019.3523

Key words

Navigation